Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Food and Agriculture Organization of the United Nations, Sub-regional Office for Eastern Africa, Addis Ababa, Ethiopia.
Lancet. 2017 Nov 25;390(10110):2397-2409. doi: 10.1016/S0140-6736(17)31510-6. Epub 2017 Jun 30.
Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated. Human African trypanosomiasis caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level. Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO. Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa. Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas. In the absence of a vaccine, disease control relies on case detection and treatment, and vector control. Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.
人类非洲锥虫病(昏睡病)是一种寄生虫感染,如果不治疗,几乎肯定会导致死亡。在 20 世纪,人类非洲锥虫病曾引发严重的流行。由于过去 15 年来持续和协调的努力,报告的病例数已降至历史最低水平。2015 年报告的病例不到 3000 例,世界卫生组织已将该病作为消除目标。尽管最近取得了这些成功,但该疾病在撒哈拉以南非洲部分地区仍呈地方性流行,对农村社区,尤其是中非地区的社区造成了巨大负担。由于也有来自非流行国家的报告病例,因此对于曾前往或居住在流行地区的旅行者、游客、移民和侨民,应考虑将人类非洲锥虫病作为鉴别诊断。由于没有疫苗,疾病控制依赖于病例检测和治疗以及病媒控制。现有的药物并不理想,但正在进行的临床试验为更安全、更简单的治疗方法带来了希望。